TrialDiabetes, obesity & metabolism2015

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).

T R Pieber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.